Education
About Us
Working with TipRanks
Follow Us
Orion Nutraceuticals, Inc. (TSE:ORI)
:ORI
RESEARCH TOOLSreports
ORI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.40 - C$0.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
C$797.31K
Enterprise ValueN/A
Total Cash (Recent Filing)C$97.34K
Total Debt (Recent Filing)C$44.91K
Price to Earnings (P/E)―
Beta0.00
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding29,307,964
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-11.02
Price to Sales (P/S)0.00
P/FCF Ratio-122.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Orion Nutraceuticals News
PremiumCompany Announcements
Orion Nutraceuticals Strengthens Leadership with New Director Appointment
PremiumCompany Announcements
Leadership Shuffle at Orion Nutraceuticals Inc.---
ORI FAQ
What was Orion Nutraceuticals, Inc.’s price range in the past 12 months?
Orion Nutraceuticals, Inc. lowest stock price was C$0.40 and its highest was C$0.40 in the past 12 months.
What is Orion Nutraceuticals, Inc.’s market cap?
Orion Nutraceuticals, Inc.’s market cap is C$797.31K.
When is Orion Nutraceuticals, Inc.’s upcoming earnings report date?
Orion Nutraceuticals, Inc.’s upcoming earnings report date is Sep 25, 2025 which is in 136 days.
How were Orion Nutraceuticals, Inc.’s earnings last quarter?
Orion Nutraceuticals, Inc. released its earnings results on Apr 18, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Orion Nutraceuticals, Inc. overvalued?
According to Wall Street analysts Orion Nutraceuticals, Inc.’s price is currently Overvalued.
Does Orion Nutraceuticals, Inc. pay dividends?
Orion Nutraceuticals, Inc. does not currently pay dividends.
What is Orion Nutraceuticals, Inc.’s EPS estimate?
Orion Nutraceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orion Nutraceuticals, Inc. have?
Orion Nutraceuticals, Inc. has 29,307,964 shares outstanding.
What happened to Orion Nutraceuticals, Inc.’s price movement after its last earnings report?
Orion Nutraceuticals, Inc. reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Orion Nutraceuticals, Inc.?
Currently, no hedge funds are holding shares in TSE:ORI
---
Company Description
Orion Nutraceuticals, Inc.
Orion Nutraceuticals Inc. focuses on the drug for treating asthma and chronic obstructive pulmonary diseases in Canada. The company was formerly known as Cline Capital Corp. Orion Nutraceuticals Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
---
Technical Analysis
---